The Concerted Action will coordinate research into novel ELISA-based serological tests with the intention of developing assay(s) able to:
1. identify infection with any serotype of FMDV by means of a single serological assay utilizing non-infectious material as antigen;
2. identify animals, whether vaccinated or not, which carry FMDV and so constitute a disease risk; and
3. identify animals infected with FMD, whether vaccinated or not, which have cleared the virus and so no longer pose a disease risk.
The Concerted Action will finance workshops to instruct experts from throughtout the Community in the performance and interpretation of the assays developed.
Call for proposalData not available
Funding SchemeCON - Coordination of research actions